DRIVE-AB policyletter regarding a European model for innovation and access to antibiotics
Academic members in the former DRIVE-AB project has completed a policyletter that suggests a new mechanism to stimulate both innovation and access to antibiotics on a European level. This mechanism is built upon the Swedish politmodel and includes generic antibiotics.
Upcoming update for Platinea's webpage
Since Uppsala University is mitigating from the editing program InfoGlue to Sitevision for it's webpages, Platinea will also mitigate and thereby update our webpage. Deadline for the mitigation is during spring 2024.
Platinea will still have the same webpage adress. But keep an eye out for the update of the page!
Platinea's fall workshop 2023 - Focus on Scandinavia
On the 19th of October, PLATINEA hosted the yearly fall-workshop. This workshop's theme was: Focus Scandinavia.
The Public Health Agency of Sweden has been assigned by the Swedish Government to conduct a prestudy regarding antibiotic stocks
The Public Health Agency of Sweden receives a government assignment to conduct a prestudy about a new compensation model for security stocks of generic antibiotics.
Summary of PLATINEA´s workshop the 3rd of may 2023, in The Swedish pharmaceutical society premises in Stockholm.
The workshop kicked-off with Thomas and Enrico welcoming all 40 participants!
PLATINEA takes part at EU: s high-level meeting on AMR!
PLATINEA will participate at EU: s high-level meeting on the question of antimicrobial resistance, which takes place in Stockholm on Monday the 6th of march.
HERA:s reports about stockpiling for a better availability of antibiotics
HERA, the European Health Emergency Preparedness and Response Authority has recently published two reports about stockpiling as a solution to increase availability of antibiotics in the EU.
Updated prioritylist of medically significant antibiotics
2022-11-15 The Public Health Agency of Sweden har collaborated with PLATINEA, within workpackage 1, to update the prioritylist of medically significant antibiotics with a unsufficient availability.
You can read the compilation here. (In Swedish).
Enrico Baraldi is awarded as "Årets Läkemedelsprofil 2022"!
Enrico Baraldi is awarded as "Årets Läkemedelsprofil 2022" for his work in Platinea.
More information. (In Swedish)
The pharmaceutical world mentions PLATINEA in the work to preserve older antibiotics
Read the article here. (In Swedish)
Three new partners to Platinea
At the General Assembly on the 14th of October this year, three new partners were voted to be a part of Platinea. We are happy to welcome Karo Pharma, Cortexa Life Science and Region Västerbotten to the collaboration platform Platinea! Platinea now consists of 21 partners.
Mapping shows risks for shortage situations of antibiotics for children
In an article from Läkemedelvärlden with Charlotta Edlund from the Public Health Agency of Sweden, the problem is raised that antibiotics for children are often listed as remaining and are difficult to replace with other medicines. The mapping, which was done within PLATINEA, indicates that a large number of antibiotics for children are at risk of disappearing from the Swedish market.
Read the article here. (In Swedish)
Suggested studies can improve the use of antibiotics
Unnecessary or incorrect use of antibiotics leads to a greater risk of developing resistance and reduced ability to treat infections. The development of new antibiotics is slow, which makes it important to improve access to and use of existing preparations. Many antibiotics that are widely used today were approved at a time when the requirements for documentation were lower.
The pandemic is teaching us to counter antibiotic shortages
Covid-19 investments can become a model - A European fund to stimulate antibiotic research according to the corona model. It was one of many proposals discussed at a seminar on Tuesday.
PLATINEA and Apotekarsocieteten coordinate event: What can we learn from covid-19 to improve access to antibiotics?
In a short time, the healthcare system and society have been quickly transformed to face the threat from the new coronavirus. International collaborations have been established, new supply chains have been established and new payment models for medicines and vaccines have been developed. How can these experiences contribute to increasing the availability of antibiotics in Sweden - in the short and long term?
PLATINEA welcomes Pfizer as a new partner
We have the pleasure to announce that Pfizer joined PLATINEA as a part May 20, 2020. We look forward to collaborate with our new part.
-Enrico Baraldi, Project manager, PLATINEA
Proposals for studies for the best possible use of antibiotics
The Public Health Agency of Sweden, in collaboration with PLATINEA, has inventoried the knowledge gaps and needs for scientific studies that exist in the area of antibiotic use.
Article in LmV - "Can AI prevent antibiotic shortages?"
An integrated, AI-based data system was one of the measures against the problem of antibiotic shortages in Sweden that was discussed at a breakfast meeting on March 10, 2020.
Article in LmV - "New report: At least 60 reasons for antibiotic shortages"
PLATINEA has mapped why there is a shortage of antibiotics in healthcare.
Article in Läkartidningen - "Antibiotics - life-threatening shortages require action"
Antibiotics have revolutionized modern medicine and are often lifesaving, if available. In 2019, 59 antibiotics were listed as backlogged, eight of which were oral suspensions. At the time of this article, 17 antibiotics were backlisted.
Läkartidningen takes up PLATINEA's proposal for safety stock to remedy backlogs
Immediately introduce a national safety stock of inpatient antibiotics. This is the message of a new report.
Article in LmV - "Want to see national stocks for antibiotics in inpatient care"
The shortage of antibiotics is so worrying that national stockpiles should be introduced immediately, according to a new report.